The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Is there a role for antibiotics in the treatment of chronic rhinosinusitis?
Abstract
Rhinosinusitis is one of the most common reasons for adult outpatient antibiotic prescriptions, though there is little clinical evidence to support this practice, especially for chronic rhinosinusitis. Despite considerable research, the etiology of chronic rhinosinusitis, including the pathogenic role of microbes, remains poorly understood. Rigorous studies of the efficacy of antibiotic treatment of chronic sinusitis are surprisingly few in number and the results are somewhat conflicting. This article will review the rationales for and against the treatment of chronic rhinosinusitis with antibiotics, based on current evidence and understanding of pathophysiology, and will also summarize the current guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While systemic and topical antibiotics are periodically administered to CRS patients and efficiently control symptomatic infections, they do not completely eradicate bacterial biofilms, leading to resistance and relapse [24,25].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Self-citationCulturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation
Browne, H. P., Forster, S. C., Anonye, B. O., Kumar, N., Neville, B. A., Stares, M. D., Goulding, D., & Lawley, T. D. (2016) · Nature · doi:10.1038/nature17645 · Cited by 1,299
Bachert, C., Mannent, L., Naclerio, R. M., Mullol, J., Ferguson, B. J., Gevaert, P., Hellings, P., Jiao, L., Wang, L., Evans, R. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.19330 · Cited by 794 · cited 1×
“(37–39) However, CRSsNP is much more common (80% of CRS cases), and CRSsNP is more endotypically heterogeneous, with subgroups of type 1 and type 3 inflammatory patterns.”
BackgroundMepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Gevaert, P., Van Bruaene, N., Cattaert, T., Van Steen, K., Van Zele, T., Acke, F., De Ruyck, N., Blomme, K., Sousa, A. R., Marshall, R. P., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.07.056 · Cited by 629
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30332-7 · Cited by 500
Oral steroids and doxycycline: Two different approaches to treat nasal polyps
Van Zele, T., Gevaert, P., Holtappels, G., Beule, A., Wormald, P. J., Mayr, S., Hens, G., Hellings, P., Ebbens, F. A., Fokkens, W., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.020 · Cited by 402
Research works printed but not linked: 122
- Smith, 2013, National burden of antibiotic use for adult rhinosinusitis, J Allergy Clin Immunol, 132, 1230, 10.1016/j.jaci.2013.07.009 · DOI
- Garbutt, 2012, Amoxicillin for acute rhinosinusitis: a randomized controlled trial, JAMA, 307, 685, 10.1001/jama.2012.138 · DOI
- Meltzer, 2005, Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo, J Allergy Clin Immunol, 116, 1289, 10.1016/j.jaci.2005.08.044 · DOI · Paper page
- Merenstein, 2005, Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial, J Fam Pract, 54, 144
- Lindbaek, 1998, Antibiotic treatment of patients with mucosal thickening in the paranasal sinuses, and validation of cut-off points in sinus CT, Rhinology, 36, 7
- Stalman, 1997, The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial, Br J Gen Pract, 47, 794
- van Buchem, 1997, Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis, Lancet, 349, 683, 10.1016/S0140-6736(96)07585-X · DOI · Paper page
- Kenealy, 2013, Antibiotics for the common cold and acute purulent rhinitis, Cochrane Database Syst Rev, 10.1002/14651858.CD000247.pub3 · DOI · Paper page
- Young, 2008, Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data, Lancet, 371, 908, 10.1016/S0140-6736(08)60416-X · DOI · Paper page
- Lindbaek, 1996, Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults, BMJ, 313, 325, 10.1136/bmj.313.7053.325 · DOI
- Hadley, 2010, Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis, Laryngoscope, 120, 1057, 10.1002/lary.20878 · DOI
- Fokkens, 2020, European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology, 58, 1, 10.4193/Rhin20.401 · DOI · Paper page
- Rudmik, 2016, Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study, Int Forum Allergy Rhinol, 6, 557, 10.1002/alr.21769 · DOI
- Orlandi, 2021, International consensus statement on allergy and rhinology: rhinosinusitis 2021, Int Forum Allergy Rhinol, 11, 213, 10.1002/alr.22741 · DOI · Paper page
- Liu, 2020, Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis, Allergy Asthma Immunol Res, 12, 176, 10.4168/aair.2020.12.2.176 · DOI
- Peters, 2014, Diagnosis and management of rhinosinusitis: a practice parameter update, Ann Allergy Asthma Immunol, 113, 347, 10.1016/j.anai.2014.07.025 · DOI · Paper page
- Rosenfeld, 2015, Clinical practice guideline (update): adult sinusitis, Otolaryngol Head Neck Surg, 152, S1
- Hoggard, 2017, Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease, Clin Microbiol Rev, 30, 321, 10.1128/CMR.00060-16 · DOI
- Bhattacharyya, 2005, Bacterial infection in chronic rhinosinusitis: a controlled paired analysis, Am J Rhinol, 19, 544, 10.1177/194589240501900602 · DOI
- Wood, 2012, Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune response, Am J Rhinol Allergy, 26, 265, 10.2500/ajra.2012.26.3779 · DOI
- Kim, 2013, The interaction between bacteria and mucosal immunity in chronic rhinosinusitis: a prospective cross-sectional analysis, Am J Rhinol Allergy, 27, 183, 10.2500/ajra.2013.27.3974 · DOI
- Verderosa, 2019, Bacterial biofilm eradication agents: a current review, Front Chem, 7, 824, 10.3389/fchem.2019.00824 · DOI · Paper page
- Vickery, 2019, The role of Staphylococcus aureus in patients with chronic sinusitis and nasal polyposis, Curr Allergy Asthma Rep, 19, 21, 10.1007/s11882-019-0853-7 · DOI
- Stewart, 2001, Antibiotic resistance of bacteria in biofilms, Lancet, 358, 135, 10.1016/S0140-6736(01)05321-1 · DOI · Paper page
- Kern, 2008, Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis, Am J Rhinol, 22, 549, 10.2500/ajr.2008.22.3228 · DOI · Paper page
- Bachert, 2001, Total and specific IgE in nasal polyps is related to local eosinophilic inflammation, J Allergy Clin Immunol, 107, 607, 10.1067/mai.2001.112374 · DOI · Paper page
- Van Zele, 2004, Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis, J Allergy Clin Immunol, 114, 981, 10.1016/j.jaci.2004.07.013 · DOI · Paper page
- Bachert, 2010, Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma, J Allergy Clin Immunol, 126, 962, 10.1016/j.jaci.2010.07.007 · DOI · Paper page
- Feazel, 2012, Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis, Laryngoscope, 122, 467, 10.1002/lary.22398 · DOI · Paper page
- Hugenholtz, 2002, Exploring prokaryotic diversity in the genomic era, Genome Biol, 3, 10.1186/gb-2002-3-2-reviews0003 · DOI
- Biswas, 2015, The nasal microbiota in health and disease: variation within and between subjects, Front Microbiol, 9, 134, 10.3389/fmicb.2015.00134 · DOI · Paper page
- Hauser, 2015, Sinus culture poorly predicts resident microbiota, Int Forum Allergy Rhinol, 5, 3, 10.1002/alr.21428 · DOI
- Ramakrishnan, 2015, Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome, J Allergy Clin Immunol, 136, 334, 10.1016/j.jaci.2015.02.008 · DOI · Paper page
- Bassiouni, 2015, Sinonasal microbiome sampling: a comparison of techniques, PLoS One, 10, 10.1371/journal.pone.0123216 · DOI
- Gevaert, 2013, Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma, J Allergy Clin Immunol, 131, 110, 10.1016/j.jaci.2012.07.047 · DOI · Paper page
- Stevens, 2017, Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease, J Allergy Clin Immunol Pract, 5, 1061, 10.1016/j.jaip.2016.12.027 · DOI · Paper page
- Stevens, 2019, Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis, J Allergy Clin Immunol Pract, 7, 2812, 10.1016/j.jaip.2019.05.009 · DOI · Paper page
- Tan, 2017, Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois, J Allergy Clin Immunol, 139, 699, 10.1016/j.jaci.2016.06.063 · doi:10.1016/j.jaci.2016.06.063
- Soler, 2013, Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations, Int Forum Allergy Rhinol, 3, 31, 10.1002/alr.21064 · DOI
- Tomassen, 2016, Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers, J Allergy Clin Immunol, 137, 1449, 10.1016/j.jaci.2015.12.1324 · DOI · Paper page
- Wang, 2016, Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania, J Allergy Clin Immunol, 138, 1344, 10.1016/j.jaci.2016.05.041 · DOI · Paper page
- Ryu, 2021, A survey on the management of chronic rhinosinusitis in the Korean Rhinologic Society, J Rhinol, 28, 44, 10.18787/jr.2020.00343 · DOI
- Lee, 2011, Regional and specialty variations in the treatment of chronic rhinosinusitis, Laryngoscope, 121, 1092, 10.1002/lary.21550 · doi:10.1002/lary.21550
- Fang, 2018, Antibiotic use patterns in endoscopic sinus surgery: a survey of the American Rhinologic Society membership, Int Forum Allergy Rhinol, 8, 522, 10.1002/alr.22085 · doi:10.1002/alr.22085
- Namyslowski, 2002, Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults, J Chemother, 14, 508, 10.1179/joc.2002.14.5.508 · DOI
- Legent, 1994, A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis, Chemotherapy, 40, 8, 10.1159/000239310 · DOI
- Hansen, 2019, Adverse events in people taking macrolide antibiotics versus placebo for any indication, Cochrane Database Syst Rev, 1
- Sadarangani, 2015, Non-anti-infective effects of antimicrobials and their clinical applications: a review, Mayo Clin Proc, 90, 109, 10.1016/j.mayocp.2014.09.006 · DOI
- Shimizu, 2016, Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan, Auris Nasus Larynx, 43, 131, 10.1016/j.anl.2015.08.014 · DOI
- Lechien, 2019, A 10-year follow-up of a randomized prospective study of 2 treatments for chronic rhinosinusitis without nasal polyps and investigation of the impact of gastroeosophageal reflux disease in the resistance to treatment, Ear Nose Throat J
- Lasso, 2017, Long-term low-dose macrolides for chronic rhinosinusitis in adults—a systematic review of the literature, Clin Otolaryngol, 42, 637, 10.1111/coa.12787 · DOI
- Spagnolo, 2013, Long-term macrolide treatment for chronic respiratory disease, Eur Respir J, 42, 239, 10.1183/09031936.00136712 · DOI
- Shimizu, 2003, In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells, Am J Respir Crit Care Med, 168, 581, 10.1164/rccm.200212-1437OC · DOI · Paper page
- Tamaoki, 1992, Effect of erythromycin on ciliary motility in rabbit airway epithelium in vitro, J Antimicrob Chemother, 29, 173, 10.1093/jac/29.2.173 · doi:10.1093/jac/29.2.173
- Takizawa, 1997, Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells, Am J Respir Crit Care Med, 156, 266, 10.1164/ajrccm.156.1.9612065 · DOI · Paper page
- Tateda, 2001, Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 45, 1930, 10.1128/AAC.45.6.1930-1933.2001 · DOI
- Yanagihara, 2002, Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model, J Antimicrob Chemother, 49, 867, 10.1093/jac/dkf013 · DOI
- Ehnhage, 2008, Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis, Int J Antimicrob Agents, 31, 561, 10.1016/j.ijantimicag.2008.01.027 · doi:10.1016/j.ijantimicag.2008.01.027
- Margaritis, 2007, Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis, Am J Rhinol, 21, 574, 10.2500/ajr.2007.21.3071 · doi:10.2500/ajr.2007.21.3071
- Fang, 2009, Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis, Int J Antimicrob Agents, 34, 67, 10.1016/j.ijantimicag.2009.01.014 · doi:10.1016/j.ijantimicag.2009.01.014
- Siu, 2020, Oral antibiotics used in the treatment of chronic rhinosinusitis have limited penetration into the sinonasal mucosa: a randomized trial, Xenobiotica, 50, 1443, 10.1080/00498254.2020.1814973 · DOI · Paper page
- Sabino, 2017, Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial, Int Forum Allergy Rhinol, 7, 135, 10.1002/alr.21846 · doi:10.1002/alr.21846
- Huck, 1993, Cefaclor vs amoxicillin in the treatment of acute, recurrent, and chronic sinusitis, Arch Fam Med, 2, 497, 10.1001/archfami.2.5.497 · DOI
- Amini, 2009, A comparing study of clarithromycin XL with co-amoxiclav for treatment of chronic sinusitis: a clinical trial, Iran J Clinic Infect Dis, 4, 197
- Fan, 2014, High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis, J Laryngol Otol, 128, 236, 10.1017/S0022215114000279 · DOI
- Jareoncharsri, 2004, An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients, Rhinology, 42, 23
- Namysłowski, 1998, Randomized clinical trial comparing the efficacy and safety of Augmentin versus cefuroxime in the treatment of chronic sinusitis in adult patients, Med Sci Monit, 4, PI551
- Head, 2016, Systemic and topical antibiotics for chronic rhinosinusitis, Cochrane Database Syst Rev, 4
- Wallwork, 2006, A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis, Laryngoscope, 116, 189, 10.1097/01.mlg.0000191560.53555.08 · DOI · Paper page
- Videler, 2011, Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial, Allergy, 66, 1457, 10.1111/j.1398-9995.2011.02693.x · DOI · Paper page
- Oakley, 2017, The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP), Curr Allergy Asthma Rep, 17, 30, 10.1007/s11882-017-0696-z · DOI
- Dubin, 2007, Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics, Ann Allergy Asthma Immunol, 98, 32, 10.1016/S1081-1206(10)60856-3 · DOI
- Sreenath, 2015, A prospective randomized cohort study evaluating 3 weeks vs 6 weeks of oral antibiotic treatment in the setting of “maximal medical therapy” for chronic rhinosinusitis, Int Forum Allergy Rhinol, 5, 820, 10.1002/alr.21542 · DOI
- Pinto Bezerra Soter, 2017, Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps, Rhinology, 55, 175, 10.4193/Rhino15.291 · DOI
- Lemiengre, 2012, Antibiotics for clinically diagnosed acute rhinosinusitis in adults, Cochrane Database Syst Rev, 10
- Ahovuo-Saloranta, 2014, Antibiotics for acute maxillary sinusitis in adults, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD000243.pub3 · DOI
- Sharp, 2007, Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002, Arch Otolaryngol Head Neck Surg, 133, 260, 10.1001/archotol.133.3.260 · DOI
- Kaszuba, 2006, Medical management and diagnosis of chronic rhinosinusitis: a survey of treatment patterns by United States otolaryngologists, Am J Rhinol, 20, 186, 10.1177/194589240602000214 · DOI
- Dubin, 2007, American Rhinologic Society member survey on “maximal medical therapy” for chronic rhinosinusitis, Am J Rhinol, 21, 483, 10.2500/ajr.2007.21.3047 · DOI
- Lund, 2005, Maximal medical therapy for chronic rhinosinusitis, Otolaryngol Clin N Am, 38, 1301, 10.1016/j.otc.2005.07.003 · doi:10.1016/j.otc.2005.07.003
- Fokkens, 2007, European position paper on rhinosinusitis and nasal polyps 2007, Rhinology Supplement, 20, 1
- Fokkens, 2012, European Position Paper on Rhinosinusitis and Nasal Polyps 2012, Rhinol Suppl, 23, 3
- Berkhout, 2013, Importance of bacteriology in upper airways of patients with cystic fibrosis, J Cyst Fibros, 12, 525, 10.1016/j.jcf.2013.01.002 · DOI
- Oomen, 2012, Sinonasal manifestations in cystic fibrosis, Int J Otolaryngol, 2012, 10.1155/2012/789572 · DOI
- Johansen, 2012, Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response, J Cyst Fibros, 11, 525, 10.1016/j.jcf.2012.04.011 · DOI
- Lim, 2014, Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis, J Clin Microbiol, 52, 425, 10.1128/JCM.02204-13 · DOI
- Price, 2013, Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation, Microbiome, 1, 27, 10.1186/2049-2618-1-27 · DOI · Paper page
- Briaud, 2019, Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells, Sci Rep, 9, 16564, 10.1038/s41598-019-52975-z · DOI
- Bonestroo, 2010, Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways, J Cyst Fibros, 9, 130, 10.1016/j.jcf.2010.01.001 · DOI
- Mainz, 2009, Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis, Thorax, 64, 535, 10.1136/thx.2008.104711 · DOI · Paper page
- Psaltis, 2007, Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis, Laryngoscope, 117, 1302, 10.1097/MLG.0b013e31806009b0 · DOI · Paper page
- Clement, 2005, Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis, J Infect Dis, 192, 1023, 10.1086/432735 · DOI · Paper page
- Kim, 2015, Chronic rhinosinusitis and cystic fibrosis: the interaction between sinus bacteria and mucosal immunity, Int Forum Allergy Rhinol, 5, 380, 10.1002/alr.21431 · doi:10.1002/alr.21431
- Bacci, 2020, Taxonomic variability over functional stability in the microbiome of cystic fibrosis patients chronically infected by Pseudomonas aeruginosa, bioRxiv
- Whelan, 2017, Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis, PLoS One, 12, 10.1371/journal.pone.0172811 · DOI
- Wagner Mackenzie, 2021, Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study, Respir Res, 22, 106, 10.1186/s12931-021-01697-w · DOI
- Karanth, 2019, Medical interventions for chronic rhinosinusitis in cystic fibrosis, Cochrane Database Syst Rev, 10
- Mainz, 2014, Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study, Drug Des Devel Ther, 8, 209, 10.2147/DDDT.S54064 · DOI
- Harvey, 2009, Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis, Immunol Allergy Clin North Am, 29, 689, 10.1016/j.iac.2009.07.006 · DOI
- Cervin, 2005, Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis, Otolaryngol Clin North Am, 38, 1339, 10.1016/j.otc.2005.08.002 · DOI
- Jaffe, 1998, Long-term azithromycin may improve lung function in children with cystic fibrosis, Lancet, 351, 420, 10.1016/S0140-6736(05)78360-4 · DOI · Paper page
- Cho, 2019, Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against Pseudomonas aeruginosa, Am J Rhinol Allergy, 33, 129, 10.1177/1945892418815615 · DOI
- Comegna, 2021, Elexacaftor-tezacaftor-ivacaftor therapy for cystic dibrosis patients with the F508del/unknown genotype, Antibiotics (Basel), 10, 828, 10.3390/antibiotics10070828 · DOI
- Shah, 2018, Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review, Int Forum Allergy Rhinol, 8, 729, 10.1002/alr.22082 · DOI
- Harvey, 2008, Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation, Otolaryngol Head Neck Surg, 139, 137, 10.1016/j.otohns.2008.04.020 · DOI · Paper page
- Goddard, 2017, Effects of endoscopic sinus surgery and device on irrigation, Otolaryngol Head Neck Surg, 139, P75
- Uren, 2008, Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis, Laryngoscope, 118, 1677, 10.1097/MLG.0b013e31817aec47 · doi:10.1097/mlg.0b013e31817aec47
- Jervis-Bardy, 2012, A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis, Laryngoscope, 122, 2148, 10.1002/lary.23486 · DOI
- Carr, 2016, Alteration in bacterial culture after treatment with topical mupirocin for recalcitrant chronic rhinosinusitis, JAMA Otolaryngol Head Neck Surg, 142, 138, 10.1001/jamaoto.2015.3059 · DOI
- Jervis-Bardy, 2012, Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery, Int Forum Allergy Rhinol, 2, 111, 10.1002/alr.20106 · DOI
- Kisiel, 2020, Development of bacterial resistance during treatment with topical gentamicin for chronic rhinosinusitis in patients with cystic fibrosis and primary ciliary dyskinesis. Retrospective case series, Otolaryngol Pol, 74, 33, 10.5604/01.3001.0013.7851 · doi:10.5604/01.3001.0013.7851
- Aanaes, 2021, Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery, Acta Otolaryngol, 141, 181, 10.1080/00016489.2020.1841909 · doi:10.1080/00016489.2020.1841909
- Cho, 2019, In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms, Int Forum Allergy Rhinol, 9, 486, 10.1002/alr.22285 · doi:10.1002/alr.22285
- Hill, 2000, The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions, J Hosp Infect, 45, 198, 10.1053/jhin.2000.0733 · DOI
- Jeronimo, 2020, Effects of povidone-iodine composite on the elimination of bacterial biofilm, Int Forum Allergy Rhinol, 10, 884, 10.1002/alr.22568 · doi:10.1002/alr.22568
- Daood, 2020, A quaternary ammonium silane antimicrobial triggers bacterial membrane and biofilm destruction, Sci Rep, 10, 10970, 10.1038/s41598-020-67616-z · DOI
- Gaurav, 2020, Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia, Int J Antimicrob Agents, 56, 10.1016/j.ijantimicag.2020.106022 · DOI
- Kamel, 2012, Preoperative skin antiseptic preparations for preventing surgical site infections: a systematic review, Infect Control Hosp Epidemiol, 33, 608, 10.1086/665723 · doi:10.1086/665723
- Jervis-Bardy, 2009, Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery, Am J Rhinol Allergy, 23, 549, 10.2500/ajra.2009.23.3366 · doi:10.2500/ajra.2009.23.3366
- Jiang, 2008, Postoperative antibiotic care after functional endoscopic sinus surgery, Am J Rhinol, 22, 608, 10.2500/ajr.2008.22.3241 · doi:10.2500/ajr.2008.22.3241
- Albu, 2010, Prophylactic antibiotics in endoscopic sinus surgery: a short follow-up study, Am J Rhinol Allergy, 24, 306, 10.2500/ajra.2010.24.3475 · doi:10.2500/ajra.2010.24.3475
- Zhang, 2014, Culture-inappropriate antibiotic therapy decreases quality of life improvement after sinus surgery, Int Forum Allergy Rhinol, 4, 403, 10.1002/alr.21277 · DOI
Cited by
Yathavan, B., Chhibber, T., Steinhauff, D., Pulsipher, A., Alt, J. A., Ghandehari, H., & Jafari, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102426 · Cited by 20
Metadata
- Authors
- Smith, S. S., Kim, R., & Douglas, R.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 149
- Issue
- 5
- Pages
- 1504-1512
- ISSN
- 0091-6749
- Cited by
- 28
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 368 d)
- Funders
- National Institute of Allergy and Infectious Diseases (U19 AI106683)
- National Institutes of Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is there a role for antibiotics in the treatment of chronic rhinosinusitis? https://app.cochat.ai/papers/10.1016/j.jaci.2022.02.004
- The paper
- Smith, S. S., Kim, R., & Douglas, R. (2022). Is there a role for antibiotics in the treatment of chronic rhinosinusitis? Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2022.02.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.